In May 2022, The US FDA authorized the use of RADICAVA ORS (edaravone) in an oral formulation for the treatment of ALS.

Target ALS today announced the launch of its newly redesigned website, a major step forward in its mission to democratize ALS research and accelerate the development of effective treatments for people ...

Neurodegenerative diseases such as Alzheimer's, Parkinson's, Huntington's, and amyotrophic lateral sclerosis (ALS) affect millions of people worldwide, yet treatments remain largely limited to symptom ...

The scientist Stephen Hawking lived with amyotrophic lateral sclerosis (ALS), the most common type of motor neuron disease, ...

By Dr. Priyom Bose, Ph.D. By reading subtle throat vibrations and pulse signals, a lightweight AI -powered choker helps ...

Dr. Ronald Joseph, the husband of St. Johns County Commissioner Krista Joseph, died Jan. 20 after a long battle with ALS.

New research from the University of St Andrews, the University of Copenhagen and Drexel University has developed AI ...

The deputy mayor of Charlottetown from Caribou Island, N.S., went into the studio with producer David Rashed in November 2024 and recorded Gail’s Guitar, not as a goodbye to her mom but about the in ...

Dr. Ronald B. Joseph, M.D. F.A.C.S., husband of St. Johns County Commissioner Krista Joseph, died peacefully on Tuesday after ...

According to Mayo Clinic, stem cells are a special type of cell that have two important properties that make more cells like ...

PRESS RELEASE AB SCIENCE RECEIVES JAPANESE PATENT PROTECTION FOR THE USE OF MASITINIB IN PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS (MS) UNTIL 2041 THIS IS THE FIRST COUNTRY DELIVERING THE MS PATENT ...

A new study from Sweden links long-term air pollution exposure to higher risk of motor neurone disease and faster progression ...